financetom
Business
financetom
/
Business
/
Crocs Names Actress Sydney Sweeney as Global Spokesperson for Heydude; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crocs Names Actress Sydney Sweeney as Global Spokesperson for Heydude; Shares Rise
Aug 22, 2024 1:22 AM

03:12 PM EDT, 08/21/2024 (MT Newswires) -- Crocs ( CROX ) said Wednesday actress Sydney Sweeney will serve as a global spokesperson for its Heydude footwear brand and also appear in Heydude content.

The shares were up more than 3% in recent Wednesday trading.

Price: 140.31, Change: +5.30, Percent Change: +3.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Life360 Swings to Q4 Earnings, Revenue Rises; 2025 Revenue Outlook Set
Life360 Swings to Q4 Earnings, Revenue Rises; 2025 Revenue Outlook Set
Feb 27, 2025
05:17 PM EST, 02/27/2025 (MT Newswires) -- Life360 ( LIF ) reported late Thursday its Q4 swung to earnings of $0.10 per diluted share from a loss of $0.05 a year earlier. Analysts surveyed by FactSet expected EPS of $0.12. Revenue for the quarter ended Dec. 31 was $115.5 million, up from $87.0 million a year ago. Analysts polled by...
Rtx Insider Sold Shares Worth $2,464,253, According to a Recent SEC Filing
Rtx Insider Sold Shares Worth $2,464,253, According to a Recent SEC Filing
Feb 27, 2025
05:12 PM EST, 02/27/2025 (MT Newswires) -- Ramsaran Maharajh, Executive Vice President and General Counsel, on February 25, 2025, sold 19,431 shares in Rtx (RTX) for $2,464,253. Following the Form 4 filing with the SEC, Maharajh has control over a total of 33,592 common shares of the company, with 29,742 shares held directly and 3,850 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/101829/000122520825002580/xslF345X05/doc4.xml...
Alkami Q4 Loss Narrows, Revenue Rises; Initiates 2025 Guidance
Alkami Q4 Loss Narrows, Revenue Rises; Initiates 2025 Guidance
Feb 27, 2025
05:14 PM EST, 02/27/2025 (MT Newswires) -- Alkami Technology ( ALKT ) posted a Q4 diluted loss Thursday of $0.08 per share, narrowing from a loss of $0.13 a year earlier. Analysts polled by FactSet also expected a loss of $0.08. Revenue for the quarter ended Dec. 31 was $89.7 million, up from $71.4 million. Analysts surveyed by FactSet expected...
Crinetics Pharmaceuticals Q4 Net Loss Narrows
Crinetics Pharmaceuticals Q4 Net Loss Narrows
Feb 27, 2025
05:14 PM EST, 02/27/2025 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) reported a Q4 net loss late Thursday of $0.88 per diluted share, narrowing from the loss of $0.90 a year earlier. Analysts polled by FactSet expected a loss of $0.89. No revenue was reported for the quarters that ended Dec. 31 in 2023 and 2024. Analysts surveyed by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved